Financhill
Back

Prothena Corp PLC 10K Form

Sell
27

PRTA
Prothena Corp PLC

Last Price:
28.98
Seasonality Move:
2.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PRTA News And Ratings

See the #1 stock for the next 7 days that we like better than PRTA

PRTA Financial Statistics

Sales & Book Value

Annual Sales: $91.37M
Cash Flow: $-52.59M
Price / Cash Flow: 0
Annual Sales: $10.46
Price / Book: 2.9

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-147.03M
Gross Margin: $0
Return on Equity: -24.59%
Return on Assets: -20.07%

Prothena Corp PLC Earnings Forecast

Key Prothena Corp PLC Financial Ratios

  • The Gross Profit Margin over the past 5 years for PRTA is 0.00%.
  • The Selling, General & Administrative Expenses for PRTA have been equal to 67.68% of Gross Profit Margin.
  • The Research & Development expenses have been 241.40% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of PRTA is -160.91% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 6 years.

Prothena Corp PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: PRTA
CUSIP: G72800
Website: prothena.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 11.24
Quick Ratio: 10.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PRTA Technical Analysis vs Fundamental Analysis

Sell
27
Prothena Corp PLC (PRTA) is a Sell

Is Prothena Corp PLC a Buy or a Sell?

  • Prothena Corp PLC stock is rated a Sell
    The current Prothena Corp PLC [PRTA] share price is $30.32. The Score for PRTA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.